Trxade Group, Inc. Gains 62.59%

Trxade Group, Inc. (MEDS:NASDAQ) rocketted at $7.17, representing a gain of 62.6%. On Wed, Jun 30, 2021, MEDS:NASDAQ touched a New 2-Week Intraday Low of $4.35. The stock appeared on our News Catalysts scanner on Wed, Jun 02, 2021 at 08:33 AM in the 'ACQUISITION' category. From Wed, Jun 16, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Jun 10, 2021 at $10.82 with a volume of 195M+, and its share price has been moving sideways in recent weeks.
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- BSKY (BSKY:NASDAQ), 2589.63%
- CPOP (CPOP:NASDAQ), 97.69%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 64.62%
- Trxade Group, Inc. (MEDS:NASDAQ), 62.59%
- Marin Software Incorporated (MRIN:NASDAQ), 40.54%
- Bridgeline Digital, Inc. (BLIN:NASDAQ), 33.72%
- AUUD (AUUD:NASDAQ), 30.32%
- Birks Group Inc. (BGI:NYSEMKT), 29.36%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 26.95%
- Grid Dynamics Holdings, Inc. (GDYN:NASDAQ), 25.08%